Home » DIAGNOSTICS TEST FOR MONITORING ANTI-HIV DRUGS HITS EUROPEAN MARKET
DIAGNOSTICS TEST FOR MONITORING ANTI-HIV DRUGS HITS EUROPEAN MARKET
A diagnostics test developed by the University of Liverpool for monitoring anti-HIV
drugs in the blood is to be made available across Europe. The test has been
acquired by Delphic Europe - a diagnostics products provider - which will develop
it in conjunction with viral resistance testing for market on the continent.
News-Medical.net
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May